Paid-members only Genomic Sequencing After 13 years, Illumina's 'little sequencer that could' has been replaced by a bigger, faster sibling
DNA I sometimes give Illumina a hard time, but they've commercialized some killer products Illumina is considered by many to have single handedly transformed the field of genomics. They did it by building on the foundation Solexa established in 1997.
Paid-members only Start-Upomics Illumina recently courted investors with a presentation on how their new product R&D pipeline is going to resurrect the Illumina stock price
Paid-members only High-Throughput Sequencing Another summer of sequencing is upon us. Whose sparkle will beguile the hearts of suitors and dazzle the eyes of onlookers?
Paid-members only Start-Upomics Featured Sighs of relief are heard as Carl Icahn's director steps down from Illumina's board
Paid-members only Genomic Sequencing Featured Illumina ruffled some feathers this week with a video appeal to moderate sized "core labs"
Paid-members only Illumina Featured Add open-source sequencers to the list of things short-read manufacturers have to deal with now
Paid-members only Genomics Featured With the FDA setting up camp in LDT-ville, which sequencing companies are best suited to help labs transition to IVDs?
Omics Featured Three predictions for all things omics in 2024 Brian Krueger’s predictions for all things Omics in 2024
Paid-members only Start-Upomics Featured Illumina and Grail 'were meant to be, just not made to last'
